{"id":62158,"date":"2025-11-07T04:03:18","date_gmt":"2025-11-07T03:03:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/"},"modified":"2025-11-07T04:03:18","modified_gmt":"2025-11-07T03:03:18","slug":"quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/","title":{"rendered":"Qu\u00e9bec Expands Access to Dexcom CGM under the R\u00e9gie de l&#8217;assurance maladie du Qu\u00e9bec (RAMQ)"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>New RAMQ coverage means eligible Qu\u00e9bec residents with type 2 diabetes on intensive insulin therapy can now access Dexcom Continuous Glucose Monitoring (CGM) to simplify diabetes management.<\/i>\n<\/p>\n<p>MONTREAL&#8211;(BUSINESS WIRE)&#8211;Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Qu\u00e9bec government for its recent decision to expand coverage of Dexcom Continuous Glucose Monitoring (CGM) Systems under the R\u00e9gie de l\u2019assurance maladie du Qu\u00e9bec (RAMQ) for eligible Qu\u00e9becers aged 18 and older living with type 2 diabetes who are treated with intensive insulin therapy (IIT)*.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/2635136\/5\/DSC_2597.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/2635136\/22\/DSC_2597.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/2635136\/5\/DSC_2597.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/2635136\/21\/DSC_2597.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/1474219\/4\/New_Dexcom_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/1474219\/22\/New_Dexcom_Logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/1474219\/4\/New_Dexcom_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/1474219\/21\/New_Dexcom_Logo.jpg\"><\/a><\/p>\n<p>\nAccording to Diab\u00e8te Qu\u00e9bec, type 2 diabetes is the most common form, affecting nearly 90% of those living with diabetes, and many eventually require insulin when lifestyle changes and oral medications are no longer enough to manage blood glucose<sup>1<\/sup>. The expansion of RAMQ coverage will grant access to Dexcom CGM for a broader population.\n<\/p>\n<p>\n\u201cThis announcement represents a significant step forward for people managing diabetes in Qu\u00e9bec and their healthcare providers, with broader access to Dexcom\u2019s advanced CGM technology,\u201d says Andr\u00e9 C\u00f4t\u00e9, Vice President and General Manager of Dexcom Canada. \u201cDexcom G7 is the most accurate CGM System<sup>\u2020,2<\/sup>, and the #1 preferred CGM by Canadian endocrinologists.<sup>\u2021,3<\/sup> 88% of CGM users with type 2 diabetes reported it helped them better understand and adjust their lifestyle<sup>4<\/sup> and the impact on their daily diabetes management was both meaningful and measurable.\u201d\n<\/p>\n<p>\n<b>R\u00e9gie de l&#8217;assurance maladie du Qu\u00e9bec (RAMQ)<\/b> \u2013 individuals must be aged two and older and meet the following criteria:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nUnder age 18: Must have type 1 diabetes.\n<\/li>\n<li>\nAge 18 and over: Must be on intensive insulin therapy (at least three injections\/day or insulin pump) and meet one or more of the following:<\/p>\n<ul class=\"bwlistcircle\">\n<li>\nHemoglobin A1C target not achieved despite optimal disease management\n<\/li>\n<li>\nFrequent hypoglycemia episodes in the past year despite adherence to a glycemia plan\n<\/li>\n<li>\nInability to recognize or signal symptoms of hypoglycemia\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\n<b>Private Insurance<\/b> \u2013 All private insurance plans must offer coverage that is at least equivalent or better than the RAMQ criteria. Most private insurance plans already cover Dexcom CGM for anyone on insulin and some plans cover anyone with diabetes.\n<\/p>\n<p>\nWith Dexcom CGM sensors, individuals can track glucose levels in real time, learn how treatments and daily choices affect their body, and discover what helps them stay in target glucose range, empowering them to feel their best and stay motivated.\n<\/p>\n<p>\n\u201cIn clinical practice, continuous glucose monitoring has significantly advanced our ability to personalize diabetes care,\u201d says Dr. Yves Robitaille, Specialist in Internal Medicine and Medical Director at the Metabolic Medicine Center of Lanaudi\u00e8re. \u201cOffering patients a range of options ensures that treatment aligns with their specific health goals and circumstances.\u201d\n<\/p>\n<p>\nDiscreet and easy to use, Dexcom G7 is the only CGM system in Canada to offer these features for insulin therapy optimization and personalization:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nPredictive Urgent Low Soon<sup>\u00a7 <\/sup>alert that can warn in advance of severe hypoglycemia<sup>5<\/sup>\n<\/li>\n<li>\nDelay 1<sup>st<\/sup> High alert after a meal that may help reduce insulin stacking<sup>6,7<\/sup>\n<\/li>\n<li>\nWaterproof sensor<sup>||<\/sup>\n<\/li>\n<li>\nFast 30-minute sensor warm-up time\n<\/li>\n<li>\nMultiple sensor wear locations<sup>\u00b6<\/sup>\n<\/li>\n<li>\nDirect to Apple Watch functionality<sup># <\/sup>\u2013 user can see glucose numbers right on their wrist\n<\/li>\n<\/ul>\n<p>\nAs the #1 patient recommended CGM in Canada<sup>**,8<\/sup>, Dexcom G7 delivers both clinical and lifestyle benefits, and now more Qu\u00e9becers than ever will have access to this technology for their diabetes management.\n<\/p>\n<p>\nTo learn more about Dexcom CGM and the public and private coverage options available, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dexcom.com%2Fen-CA&amp;esheet=54353446&amp;newsitemid=20251106123887&amp;lan=en-US&amp;anchor=dexcom.com.&amp;index=1&amp;md5=8dd669e8871532777ec739ad73e3e07d\" rel=\"nofollow\" shape=\"rect\">dexcom.com.<\/a>\n<\/p>\n<p>\n<b><span class=\"bwuline\">About Dexcom<\/span><\/b>\n<\/p>\n<p>\nDexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in continuous glucose monitoring for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.\n<\/p>\n<p>\nDexcom. Discover what you\u2019re made of.\n<\/p>\n<p>\nFor more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dexcom.com&amp;esheet=54353446&amp;newsitemid=20251106123887&amp;lan=en-US&amp;anchor=www.dexcom.com&amp;index=2&amp;md5=8acd1e1f64a4887a68e2bc052cee4c9f\" rel=\"nofollow\" shape=\"rect\">www.dexcom.com<\/a>.\n<\/p>\n<p>\nCategory: IR\n<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\">\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n* <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dexcom.com%2Fen-CA%2Fcoverage%2Fquebec-ramq-provincial-cgm-coverage&amp;esheet=54353446&amp;newsitemid=20251106123887&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.dexcom.com%2Fen-CA%2Fcoverage%2Fquebec-ramq-provincial-cgm-coverage&amp;index=3&amp;md5=4f68d55e086221f062ac154436516070\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.dexcom.com\/en-CA\/coverage\/quebec-ramq-provincial-cgm-coverage<\/a>\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u2020 When compared with CGM systems commercially available in Canada as of October 2025. Sensors worn on the back of the upper arm have been found to be slightly more accurate than sensors worn on the abdomen.\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<sup>\u2021<\/sup> Based on a survey of Canadian Endocrinologists (n=41)\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a7 Audible and visual notification of predictive alert at 3.1 mmol\/L within 20 minutes.\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n|| The Dexcom G7 Sensor is waterproof and may be submerged under eight feet of water for up to 24 hours without failure when properly installed.\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00b6 Indicated for wear on the back of the upper arm and abdomen for ages 2 years and older or the upper buttocks for ages 2-6 years old.\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n# Smart device sold separately. To view a list of compatible devices, visit dexcom.com\/compatibility. Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch.\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n** Based on a comparison in NPS scores across major CGM brands\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n1 <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.diabete.qc.ca%2Fen%2Fdiabetes%2Finformation-on-diabetes%2Ftype-2-diabetes%2F&amp;esheet=54353446&amp;newsitemid=20251106123887&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.diabete.qc.ca%2Fen%2Fdiabetes%2Finformation-on-diabetes%2Ftype-2-diabetes%2F&amp;index=4&amp;md5=e93121baba31c417a4f89132f7ad0f7c\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.diabete.qc.ca\/en\/diabetes\/information-on-diabetes\/type-2-diabetes\/<\/a>\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n2 Dexcom, data on file, 2025\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n3 Q&amp;A, Dexcom Canadian Endos Report Wave 1 2024\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n4 Dexcom, Data on File, 2024.\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n5 Dexcom G7 User Guide.\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n6 Aly A, et al. Diabetes Technol. Ther. 2024;26(S2): A254-255.\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n7 Puhr S, et al. Diabetes Technol Ther. 2019;21(4):155-158.\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n8 DQ&amp;A, Canada Diabetes Connections Patient Panel Report, H1 2024\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\n\u00a0\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Contact:<\/b><br \/>Daphn\u00e9e Marcil<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;&#58;&#77;arc&#x69;&#x6c;&#x40;&#x6c;&#x75;&#120;&#105;&#110;eve&#x72;&#x69;&#x74;&#x61;&#x73;&#46;&#99;&#111;m\" rel=\"nofollow\" shape=\"rect\">&#x4d;&#x61;&#x72;&#x63;&#x69;&#x6c;&#x40;&#x6c;&#x75;&#x78;&#x69;&#x6e;&#x65;&#x76;&#101;&#114;&#105;&#116;&#97;&#115;&#46;&#99;&#111;&#109;<\/a><br \/>450-820-5253\n<\/p>\n<p>\n<b>Investor Contact:<\/b><br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#x3a;&#x69;n&#118;&#101;&#x73;&#x74;o&#114;&#x2d;&#x72;e&#108;&#x61;&#x74;i&#111;&#110;&#x73;&#x40;d&#101;&#x78;&#x63;o&#109;&#x2e;&#x63;o&#109;\" rel=\"nofollow\" shape=\"rect\">&#x69;&#x6e;&#118;&#101;st&#x6f;&#x72;&#x2d;&#114;el&#x61;&#x74;&#x69;&#111;&#110;s&#x40;&#x64;&#x65;&#120;&#99;o&#x6d;&#x2e;&#x63;&#111;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>New RAMQ coverage means eligible Qu\u00e9bec residents with type 2 diabetes on intensive insulin therapy can now access Dexcom Continuous Glucose Monitoring (CGM) to simplify diabetes management. MONTREAL&#8211;(BUSINESS WIRE)&#8211;Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Qu\u00e9bec government for its recent decision to expand coverage of Dexcom Continuous Glucose Monitoring (CGM) &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62158","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Qu\u00e9bec Expands Access to Dexcom CGM under the R\u00e9gie de l&#039;assurance maladie du Qu\u00e9bec (RAMQ) - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Qu\u00e9bec Expands Access to Dexcom CGM under the R\u00e9gie de l&#039;assurance maladie du Qu\u00e9bec (RAMQ) - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"New RAMQ coverage means eligible Qu\u00e9bec residents with type 2 diabetes on intensive insulin therapy can now access Dexcom Continuous Glucose Monitoring (CGM) to simplify diabetes management. MONTREAL&#8211;(BUSINESS WIRE)&#8211;Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Qu\u00e9bec government for its recent decision to expand coverage of Dexcom Continuous Glucose Monitoring (CGM) ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-07T03:03:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/2635136\/22\/DSC_2597.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Qu\u00e9bec Expands Access to Dexcom CGM under the R\u00e9gie de l&#8217;assurance maladie du Qu\u00e9bec (RAMQ)\",\"datePublished\":\"2025-11-07T03:03:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\\\/\"},\"wordCount\":882,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251106123887\\\/en\\\/2635136\\\/22\\\/DSC_2597.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\\\/\",\"name\":\"Qu\u00e9bec Expands Access to Dexcom CGM under the R\u00e9gie de l'assurance maladie du Qu\u00e9bec (RAMQ) - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251106123887\\\/en\\\/2635136\\\/22\\\/DSC_2597.jpg\",\"datePublished\":\"2025-11-07T03:03:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251106123887\\\/en\\\/2635136\\\/22\\\/DSC_2597.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251106123887\\\/en\\\/2635136\\\/22\\\/DSC_2597.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Qu\u00e9bec Expands Access to Dexcom CGM under the R\u00e9gie de l&#8217;assurance maladie du Qu\u00e9bec (RAMQ)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Qu\u00e9bec Expands Access to Dexcom CGM under the R\u00e9gie de l'assurance maladie du Qu\u00e9bec (RAMQ) - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/","og_locale":"en_US","og_type":"article","og_title":"Qu\u00e9bec Expands Access to Dexcom CGM under the R\u00e9gie de l'assurance maladie du Qu\u00e9bec (RAMQ) - Pharma Trend","og_description":"New RAMQ coverage means eligible Qu\u00e9bec residents with type 2 diabetes on intensive insulin therapy can now access Dexcom Continuous Glucose Monitoring (CGM) to simplify diabetes management. MONTREAL&#8211;(BUSINESS WIRE)&#8211;Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Qu\u00e9bec government for its recent decision to expand coverage of Dexcom Continuous Glucose Monitoring (CGM) ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-07T03:03:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/2635136\/22\/DSC_2597.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Qu\u00e9bec Expands Access to Dexcom CGM under the R\u00e9gie de l&#8217;assurance maladie du Qu\u00e9bec (RAMQ)","datePublished":"2025-11-07T03:03:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/"},"wordCount":882,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/2635136\/22\/DSC_2597.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/","url":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/","name":"Qu\u00e9bec Expands Access to Dexcom CGM under the R\u00e9gie de l'assurance maladie du Qu\u00e9bec (RAMQ) - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/2635136\/22\/DSC_2597.jpg","datePublished":"2025-11-07T03:03:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/2635136\/22\/DSC_2597.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251106123887\/en\/2635136\/22\/DSC_2597.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/quebec-expands-access-to-dexcom-cgm-under-the-regie-de-lassurance-maladie-du-quebec-ramq\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Qu\u00e9bec Expands Access to Dexcom CGM under the R\u00e9gie de l&#8217;assurance maladie du Qu\u00e9bec (RAMQ)"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62158","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62158"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62158\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62158"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62158"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62158"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}